DTL
YMAB

Dynamic Technology Lab’s Y-mAbs Therapeutics YMAB Stock Holding History

Dynamic Technology Lab’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,478
Closed -$128K – 1473
2023
Q1 		$128K Buy
+25,478
New +$104K 0.01% 955
2021
Q2 		– Sell
-6,790
Closed -$205K – 1603
2021
Q1 		$205K Buy
+6,790
New +$278K 0.02% 948
2020
Q3 		– Sell
-7,933
Closed -$343K – 1399
2020
Q2 		$343K Buy
+7,933
New +$300K 0.05% 623

Other funds holding YMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dynamic Technology Lab's YMAB Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Y-mAbs Therapeutics (YMAB) in Q2 2023, closing a stake of 25,478 shares — an estimated $128K sold.

Dynamic Technology Lab first reported a position in YMAB in Q2 2020 and held it in 3 quarters. The position peaked at $343K in Q2 2020. 95 funds tracked by Wall St. Rank hold YMAB as of Q2 2023.

  • Dynamic Technology Lab reported no remaining Y-mAbs Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 25,478 Y-mAbs Therapeutics shares in Q2 2023, an estimated $128K.
  • Dynamic Technology Lab first reported a position in Y-mAbs Therapeutics in Q2 2020 and held it in 3 quarters.
  • Dynamic Technology Lab's Y-mAbs Therapeutics position peaked at $343K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.